Prostate cancer screening saves many more lives than earlier studies suggested, research shows. The results from the longest-running European trial show one life saved for every six men diagnosed, a ...
US-based biopharmaceutical company Spinogenix has concluded the enrolment of patients in its Phase II clinical trial of tazbentetol (previously known as SPG302), a synaptic regenerative treatment for ...
Vertical health delivery programmes were highly effective in rapid roll-out of HIV services in high-burden countries in southern and eastern Africa. With improved access to care and increased life ...
At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs. those using finger pricking1,2Improvements were participant-led, ...
Social media has made fitness advice more accessible than ever, but a review has raised concerns about the accuracy and ...
Ancient wisdom tells us that evil grows in ignorance. But worse than ignorance, as Stephen Hawking once warned, is the ...
A world-first trial of Australian men has confirmed a specialised scan can accurately “light up” prostate cancer, saving unnecessary and painful biopsies and stress of over-diagnosis.
Is it game over for this stock? Let's find out. The post Game over? ASX biotech stock crashes 90% on big bad news appeared first on The Motley Fool Australia.
Research suggests haemodiafiltration convection volume could be individualised to optimise clearance. Learn more about this study.
Bumble Inc unveiled a new artificial intelligence-powered assistant designed to act as a personal matchmaker, the company's ...
NHS partners have found that AI-based CBT can outperform human clinical judgment when treating individuals with moderate depression and anxiety, while achieving comparable therapeutic alliance and ...
Enrollment has been completed for a phase 2a randomized clinical trial evaluating the investigational microbiome therapeutic EBX-102-02 in patients undergoing allogeneic hematopoietic stem cell ...